- Brak danych
Polski
 - English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Physicists have been working hard to improve the accuracy of atomic clocks, which are the most precise timing devices currently available. A promising way to achieve higher accuracy is to utilize spin squeezed states in clock atoms.Spin squeezed states are entangled quantum states in which particles work together to counteract their inherent quantum noise. These states provide incredible potential...
Scientists from the University of Hahn in Spain and the University of Santiago de Compostela conducted research to determine the most suitable semiconductor materials for high-power light transmission in terrestrial and underwater environments.HPOT, also known as laser power transfer, is a method of transmitting continuous power to a remote system using a monochromatic light source through an opti...
Recently, the team of Situ Guohai and Guo Jinying from the Aerospace Laser Technology and Systems Department of the Shanghai Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, and the School of Microelectronics at Shanghai University collaborated to propose a terahertz phase controlled programmable metasurface design scheme based on free carrier plasma dispersion effect. The rela...
2Pi Optics has launched a new type of fisheye camera based on its so-called metasurface optics.The company plans to showcase this technology at the large-scale technology trade show CES 2024 in Las Vegas next week.This company, headquartered in Cambridge, Massachusetts, stated that it has created the world's leading high-resolution fisheye sensor based on optical superlens technology. This technol...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...